Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04565119 · ClinicalTrials.gov registry record

Biomarkers in the Brain Oxygen Optimization in Severe Traumatic Brain Injury Trial

A clinical trial of TBI (Traumatic Brain Injury), sponsored by University of Pennsylvania.

Recruiting
Registry status
300
Enrollment target
2
Study locations

NCT04565119: Recruiting study of TBI (Traumatic Brain Injury), sponsored by University of Pennsylvania.

NCT04565119 is a study of TBI (Traumatic Brain Injury) that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 300 participants, above the 158-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (90% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04565119, a study of TBI (Traumatic Brain Injury), is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
300 participants
Enrollment target
2
Study locations

Study Summary

BioBOOST is a multicenter, observational study of the effect of derangements in brain physiologic parameters on brain injury biomarker levels in patients with severe traumatic brain injury.

Interventions

  • OTHER No intervention. This is an observational study.

Study Locations (2)

Michigan

  • University of Michigan - Ann Arbor

Pennsylvania

  • Penn Presbyterian Medical Center - Philadelphia

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2020-12-20
Est. Completion 2027-12-31

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT04565119

The ClinicalTrials.gov registry entry for NCT04565119 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 158-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (90% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with TBI (Traumatic Brain Injury) appearing as the primary indexed condition, and to 1 intervention - of which No intervention. This is an observational study. is the first listed.

NCT04565119 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Michigan, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04565119 about?

NCT04565119 is a clinical study titled "Biomarkers in the Brain Oxygen Optimization in Severe Traumatic Brain Injury Trial". BioBOOST is a multicenter, observational study of the effect of derangements in brain physiologic parameters on brain injury biomarker levels in patients with severe traumatic brain injury.

What is the current status of trial NCT04565119?

This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2020-12-20. Estimated completion is 2027-12-31.

What conditions does trial NCT04565119 study?

This clinical trial studies the following conditions: TBI (Traumatic Brain Injury).

What interventions are being tested in trial NCT04565119?

The interventions under investigation include: No intervention. This is an observational study. (OTHER).

Who is sponsoring clinical trial NCT04565119?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04565119 being conducted?

This trial has 2 study locations across Michigan, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for TBI (Traumatic Brain Injury)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.